| Log in
Photo Credit: Strides Arcolab Ltd.

Strides Arcolab to raise up to $227M

28 September, 2015

Strides Arcolab Ltd, a Bangalore-based pharmaceutical company, has received its board’s approval to raise up to Rs 1,500 crore ($226.8 million) including a green-shoe option, according to a stock market disclosure.

It will be raising the funds by way of issuing GDRs/ADRs/FCCBs, QIP or such other equity linked instruments, the company said.

Founded in 1990, the company offers general tablets, hard- and soft-gelatin capsules, sachets, potent drugs and semi-solids.

In May this year, Strides Arcolab signed a deal to acquire South African drugmaker Aspen Pharmacare’s generic pharmaceutical business in Australia together with certain branded pharma assets.

Last year, it struck three deals including two in India. The company made a strategic investment in Oncobiologics Inc and also bought a majority stake in branded generics business of Chennai-based Bafna Pharmaceutical and announced an all-stock deal to buy Shasun Pharma.

Shares of Strides Arcolab were trading at Rs 1,237 each, down 0.11 per cent on BSE in a weak Mumbai market on Monday at 1.22 PM.


Leave Your Comment
Strides Arcolab to buy seven brands from J&J, part of Medispan

Strides Arcolab to buy seven brands from J&J, part of Medispan

Debjyoti Roy 2 years ago
Bangalore-based pharmaceutical company Strides Arcolab Ltd has struck a deal to...
Strides Arcolab Mulling Sale Of Generic Pharma To SeQuent

Strides Arcolab Mulling Sale Of Generic Pharma To SeQuent

Boby Kurian 8 years ago
Bangalore-based mid-sized and deal-savvy Strides Arcolab may be exploring the...
Strides Arcolab to buy Aspen's generic pharma business in Australia for $300M

Strides Arcolab to buy Aspen’s generic pharma business in Australia for $300M

Jasleen Kaur Batra 3 years ago
Strides Arcolab Ltd has inked a deal to buy South African drugmaker Aspen...
No Comments

Strides Arcolab to raise up to $227M

Powered by WordPress.com VIP